■ BACKGROUND AND MOTIVATION
Bioelectronics involves the union of electronics with biological systems such that the electronics can monitor or modulate properties of the system or both. 1−4 The field has a long history, from Galvani's 1780s studies of exciting frog muscles 3 to current medical devices, including implanted cardiac pacemakers and deep brain stimulators. 4 Remarkably, these latter medical devices have many of the same bioelectronic interface features as in Galvani's experiments, comparatively rigid metal electrode surfaces in contact with soft tissues. For example, implantable microwires and silicon-based neural probes with microscale metal devices have allowed recording of brain activity with single neuron level spatiotemporal resolution in live animals and even human subjects. 4 Yet, the large mismatch in stiffness between these probes and brain tissue results in relative shear motion, glial scar formation, and neuron depletion at the probe−brain interfaces 5 that prevent long-term tracking of the same neurons and their encompassing neural circuits. In essence, the bioelectronic devices have very little similarity to the biological system they are designed to monitor.
One approach we initiated over a decade ago to bridge the gap between electronic and biological systems centered on incorporating nanoscale devices to enable individual elements to interface at the subcellular level as occurs naturally in biology. 6, 7 For example, we introduced two-dimensional (2D) chip-based arrays of nanowire field-effect-transistors (FETs) capable of mapping highly localized action potentials (APs) from cultured neurons and acute brain slices with subcellular resolution, 7, 8 showing the capability to record both APs from the localized synapse-like junctions formed by neurites crossing individual nanowire FETs 7 and localized excitatory postsynaptic potential 8 not possible with conventional metal microelectrodes.
Recognizing the limitation of planar electronics for interfacing with three-dimensional (3D) biological systems also led us, through the deep understanding and synthetic versatility of nanowires, 2, 3 to develop the first 3D nanowire FET nanoprobes. 9 These 3D nanoprobes were enabled by introducing two cis-topological kinks or stereocenters during nanowire growth to localize an active FET at the tip of an acute-angle kinked silicon nanowire. 9 This approach allowed for localization of a point-like detector away from the microscale electrical contacts and, following surface functionalization with phospholipid bilayers, yielded cellular internalization and intracellular recording with minimal external forces using both substrate-based and fully free-standing 3D kinked nanowire probes. 9, 10 These studies have demonstrated how advances in nanoelectronics enabled by synthesized nanowire devices allow for interfacing at scales more relevant to biology, yet the presentation of these arrays of devices on relatively rigid substrates 6−9 or as individual probes 10 has precluded 3D seamless integration of bioelectronic systems with synthetic and natural tissues.
To overcome this major limitation that has persisted in the field since Galvani's work, 3 we have focused on development of a new paradigm for bioelectronics, tissue-like electronics, in which we create 3D networks of addressable devices where all elements of the network have cellular or subcellular dimensions, the network mechanical properties are similar to the tissue, and the network structure allows both 3D interpenetration of cells and diffusion of biochemical species ( Figure 1) . 2,3,11−15 Below we describe the implementation of this paradigm within the context of seamless 3D integration of nanoelectronics with synthetic tissues and live animals, including unique capabilities for stable 3D monitoring and modulation of cellular or tissue activity relevant to areas from pharmacological screening in cardiac tissue patches to single neuron level changes associated with aging, and then conclude a discussion of where we foresee substantial future opportunities in fundamental research through electronic therapeutics.
■ MESH NANOELECTRONICS
Our paradigm for tissue-like electronics consisting of a macroporous mesh structure with addressable electronic devices (Figure 1 ), hereafter termed mesh nanoelectronics, was first realized in terms of the analogous biological functional elements across nanometer-to-centimeter size scales. 11 At the individual device level, it is possible to incorporate semiconductor nanowires with rationally defined properties 2,3,6−10 as subcellular size active sensors or metal microelectrodes as cellular size passive sensors or larger-scale stimulators. 12−15 At the network level, the macroporous mesh structure with addressable devices is readily fabricated by standard lithography methods on a 2D substrate first coated with a release layer. In this process, we use an organic resist, which is converted to a biocompatible polymer during lithography processing, both as the key structural material for the mesh and as the material embedding and passivating the ultrathin metal interconnects, while leaving the nanowire or metal devices exposed. Following fabrication and release from the substrate, the mesh nanoelectronics can be transformed into different 3D topologies and seeded with cells to yield electronically innervated synthetic tissues ( Figure 1 This general strategy allows facile tailoring of all key elements and the properties of the mesh nanoelectronics. For example, the device type, spatial configuration, and number are readily defined in a deterministic manner by a combination of assembly 16, 17 and lithography to meet specific design goals for experiments. In addition, the structural design of the mesh nanoelectronics, including the width, thickness, and unit cell of the polymer elements, is used to control the mechanical properties such that they are comparable to those of tissues being targeted, 12−14 as well as allow for 3D interpenetration of different cell types and diffusion of important biochemical species. Below we first focus on the studies of mesh nanoelectronics for 3D innervation of synthetic tissues 11, 12 and then make a conceptual jump forward with seamless 3D integration within the brain. 11, 12, 21 First, the substrate portion of the mesh nanoelectronics is transformed from planar asfabricated structure to a specific 3D configuration by exploiting either built-in strain for self-organization or mechanical deformations such as folding or rolling-up (Figure 2A ). The mesh nanoelectronics structure is either seeded with specific cell types directly or first combined with a conventional passive biomaterial scaffold, such as collagen, alginate, or PLGA, before cell seeding. Finally, the mesh nanoelectronics hybrid with cells is cultured to fully develop the 3D innervated tissues, where measurements can be carried out both during tissue maturation and in a fully developed state.
For example, embryonic rat hippocampal neurons were cultured in a rolled-up mesh nanoelectronics hybrid with silicon nanowire FETs to yield 3D innervated neural tissues. 11 Notably, the 3D confocal micrograph ( Figure 2B ) of the hybrid recorded following 2-week culture showed clearly seamless interpenetration of the neural network and similar feature size mesh nanoelectronics, with individual neurites often passing through the ring structures supporting individual nanowire FETs. This intimate nanoelectronic/neural interface further allowed for multiplexed 3D recording of local field potential (LFP) activity induced by addition of glutamate and subsequent suppression of activity by synaptic blockers ( Figure  2C ). A second example and one that follows directly from the rollup concept is the development of innervated vascular tissue constructs. 11 Schematics and experimental demonstrations of this concept ( Figure 2D ,E) show human aortic smooth muscle cells (HASMCs) initially cultured on 2D mesh nanoelectronics ( Figure 2D (i),E) to develop an intimate mesh nanoelectronicsHASMCs interface, followed by rolling into multilayer 3D tubular structures and further culture to yield matured vascular constructs without macroscopic delamination or desquamation ( Figure 2D (ii),E). Cross-sectional images of the stained innervated vascular construct ( Figure 2F ) revealed tight integration of elongated cells, collagenous nanofibers, and embedded mesh nanoelectronics. These hybrid constructs with chemical sensing capabilities of the nanowire FETs 6 were used as a platform to monitor pH through the tissue as the endovascular and extravascular pH was varied ( Figure 2D(iii) ). Notably, as the extravascular pH was varied stepwise with luminal pH fixed, nanowire FETs in the outermost layer tracked this pH change, while the devices in the innermost layer showed minor baseline fluctuations ( Figure 2G ). These mesh nanoelectronics-innervated vascular constructs thus demonstrate capability as biomedical devices to study inflammation, ischemia, tumor microenvironments, or other forms of metabolic acidosis. 22, 23 A third example where mesh nanoelectronics/synthetic tissues have been examined in considerable detail centers on innervated cardiac tissue patches. 12 For example, neonatal rat ventricular cells seeded in mesh nanoelectronics/PLGA hybrid scaffolds can be readily "folded" to yield 3D innervated structures ( Figure 3A ) with multiple layers of addressable nanoelectronic devices for monitoring and modulating tissue behavior. 12 A 3D confocal fluorescence image of a typical hybrid following 7 days of culture ( Figure 3B ) reveals a high density of cardiomyocytes in close contact with and aligned to the mesh nanoelectronics. Extended 2−3 week time scale studies showed little effect of the mesh nanoelectronics on the cell viability, thus demonstrating long-term biocompatibility. Additionally, multiplexed recording of extracellular cardiac APs ( Figure 3C ) demonstrate single-shot sub-millisecond resolution, which has been exploited to map the time latency between signals from one ( Figure 3D ) or multiple device layers ( Figure  3E ) associated with AP propagation across the 3D tissue.
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This 3D mapping capability has been exploited to explore several areas in unique ways including tissue development, arrhythmia disease models and closed-loop electronic therapeutics. 12 First, 3D real-time mapping of APs carried out at 2, 4, 6, and 8 days in vitro revealed expansion of spontaneous beating regions with volume percentage of detectable activity increasing from ca. 50% to 98% over this period. The unique capability to directly map 3D functional network provides an advanced method to study tissue engineering and regeneration, including studies of stem cell differentiation, growth factors, and ischemia. In addition, focal injection of norepinephrine, a β-adrenergic receptor agonist, was used as an model system to induce arrhythmia. 24 Following injection at one position of an innervated cardiac tissue ( Figure 3F ), simultaneous real-time recording of APs in 3D ( Figure 3G ) yielded clear evidence for arrhythmia and subsequent tissue self-adaptation with millisecond resolution. Representative data from three nanowire FET sensors in different layers before and after norepinephrine injection ( Figure 3G,H) highlighted the dynamic instability of the conduction pathway, where the AP initially propagated from sensor L3(4,1) to L1(4,3) before the injection, followed by an earlier depolarization around sensor L1(4,3) leading to reversal of the propagation direction 5−10 s postinjection. These critical spatiotemporal variations associated with norepinephrine and other drugs 11, 12 would be difficult to detect using methods that require scanning and averaging of APs in 3D 25 and highlight one of the clear advantages of our mesh nanoelectronics 3D innervated tissues as models for pharmacological screening in the future.
Finally, we have also investigated cardiac tissues innervated with multifunctional mesh nanoelectronics incorporating both sensor and stimulator devices as a step toward closed-loop nanoelectronics−tissue hybrids as implants ( Figure 4A ). 12 Significantly, application of a stimulation spike train (1 V, 1.25 Hz) in the mesh nanoelectronics-innervated cardiac tissue ( Figure 4B ) locked the AP peaks recorded in different regions of the tissue to the stimulation. Moreover, with the same conditions it is possible to control precisely AP propagation direction; that is, sequential stimulation at different corners of the hybrid tissue rotated the AP propagation directions by 90°a t each step ( Figure 4C−F) . 12 These results provide a proof-ofconcept for closed-loop control of implanted cardiac patches that would allow for precise monitoring and modulation of cardiac electrophysiology postsurgery, a critical capability not currently possible with conventional stimulators. 26 
■ MESH NANOELECTRONICS IN LIVE ANIMALS
Moving from mesh nanoelectronics/synthetic tissue hybrids to innervating tissue in live animals requires several hurdles to be addressed. First, a minimally invasive method that affords precise targeting of specific tissue regions is needed to implant the mesh nanoelectronics. Second, the responses of the tissue and cells to the mesh nanoelectronics must be characterized; that is, whether it elicits an immune response. Third, an input/ output (I/O) instrument interface compatible with minimally invasive delivery and in vivo measurements is needed to explore the potentially unique characteristics of the tissue-like electronics. We discuss each of these key points within the context of implanting the mesh nanoelectronics into the brains of live rodents.
To solve the challenge of minimally invasive delivery, we proposed and demonstrated a unique solution whereby the mesh nanoelectronics is treated as a "biological reagent" that is delivered to the tissue by syringe injection ( Figure 5) . 13, 18 The mesh nanoelectronics for brain implantation are similar to that discussed above with the additional neural tissue-like/syringe injection constraints of (i) mesh element widths that are no bigger than somata, mechanical flexibility similar to brain tissue and capable of rolling-up in syringe needles, and (ii) nanoelectronic devices positioned to target desired brain regions with interconnects sufficiently long so that I/O connections are well outside the skull postinjection ( Figure  5A ). For example, we have shown that a 2 mm-wide mesh nanoelectronics can be readily loaded into a 95 μm inner diameter glass needle ( Figure 5B ) and then partially injected into and unrolled in saline solution ( Figure 5C ). 13 To achieve precise injection and targeting of distinct brain regions, we developed a semiautomated field-of-view injection process that can be adapted to standard rodent (as well as nonhuman primate and human) stereotaxic surgery stages ( Figure 5D ). Significantly, this method yields ca. 20 μm targeting precision with fully extended mesh morphology as confirmed by microcomputed tomography (micro-CT) ( Figure 5E ), 18 thereby allowing specific brain regions or layers to be targeted with mesh devices.
The response of brain tissue to conventional flexible thin-film probes ( Figure 6A ) and implanted ultraflexible mesh nanoelectronics ( Figure 6B ) has been evaluated by time-dependent immunohistology studies. 19 First, conventional state-of-the-art flexible electronic probes elicit classic immune response with elevated levels of markers for microglia (Iba-1) and astrocytes (GFAP) and suppression of neurons (NeuN) for all times at the probe interface ( Figure 6A ). In contrast, brain tissue implanted with mesh nanoelectronics exhibited only slight overexpression of Iba-1 and GFAP, as well as no decrease in neuron signals, at the shortest 2 week time point and, importantly, showed that markers for immune response, Iba-1 and GFAP, and neurons and axons, NeuN and Neurofilament, are all essentially the same as natural background level by 4−6 weeks and maintain this natural distribution of cells to at least 1-year at the probe interface ( Figure 6B) . 14 In addition, these studies have documented the time-dependent penetration of axonal projections and somata into the interior of mesh nanoelectronics such that near natural cell distributions are achieved both internally and externally to the mesh nanoelectronics at longer times; that is, seamless integration with the brain. This seamless integration is important in that it allows studies to be carried out on natural neural tissue versus that with extrinsic damage and, moreover, suggests unique possibilities for stable long-term monitoring and modulation of neural circuitry.
To carry out chronic multiplexed recording and stimulation studies using syringe-implanted mesh nanoelectronics we have implemented two reliable methods for multichannel I/O connection to standard measurement electronics, including automated conductive ink printing 18 and more recently a "plugand-play" interface. 20 The plug-and-play method ( Figure 7A ) is particularly attractive because it is a rapid and user-friendly approach that can be readily adopted by nonexperts in the neuroscience community and also can be adapted to protocols necessary for a human surgical environment. This interface approach retains a standard ultraflexible, tissue-like mesh region for implantation in the brain ( Figure 7A(i) ), and then routes all interconnect lines via a stem region ( Figure 7A (ii)) to individually addressed I/O pads with size and pitch matching standard zero insertion force (ZIF) connectors ( Figure  7A(iii) ), thus allowing "by hand" plug-and-play connection to standard instrument interface boards ( Figure 7A(iv) ). For example, connection to a printed circuit board with a standard Omnetics connector yields a compact head-stage for acute and chronic multiplexed recording and stimulation studies in freely behaving animals ( Figure 7B) .
The above results demonstrating precise implantation, seamless tissue integration, and facile instrument interfacing of the mesh nanoelectronics together allow for chronic electrophysiology studies, where the tissue-like mechanical properties and immune response free mesh−tissue interface point to the potential for highly stable chronic measurements. Indeed, we demonstrated single-neuron level recording and stimulation of the same neurons and local circuits on a year time scale in mice, 14 with key results as follows. First, 16-channel multiplexed recordings at 2 and 4 months postinjection showed stable modulation of LFPs and consistent amplitudes of single-unit spikes ( Figure 7C ). Statistical analyses of recorded single-unit spikes over an 8 month period further revealed stable tracking of the same individual neurons based on consistent principal component analysis (PCA, Figure 7D ), similar average spike waveforms ( Figure 7E ), and largely unchanged interspike interval (ISI) histograms ( Figure 7F ) and firing rates.
14 In addition, stable phase locking ( Figure 7G ) for single-neuron firings and theta oscillations in the hippocampus demonstrate the capability to stably monitor the same single neurons and encompassing neural circuits.
Finally, we also incorporated stimulation electrodes into the mesh nanoelectronics as a step toward achieving bidirectional, closed-loop communication with the brain.
14 Simultaneous stimulation and recording at the single-neuron level ( Figure  7H) show significantly increased firing rates, which are consistent with stimuli-evoked single-unit responses, in peristimulus spike raster plots. Moreover, first-spike latency histograms following stimulation along with spike sorting and PCA ( Figure 7I) show stable single-neuron responses to chronic electrical stimulation over at least a 3-month period.
■ CONCLUSIONS AND OUTLOOK
The mesh nanoelectronics described in this Account represent a new paradigm for seamless integration of electronics with biological systems. The macroporous mesh with individually addressable nanoelectronic devices is distinct from passive biomaterial scaffolds and conventional flexible electronics and has exceptional compatibilities in terms of chronically stable innervation of synthetic tissues and live animals. With the incorporation of biochemical and electrical sensors, as well as stimulators, in mesh nanoelectronics-innervated tissues, we have demonstrated a 3D electrophysiological mapping and manipulation platform with high temporal resolution to study tissue development, pharmacological responses, and disease mechanisms. Minimally invasive delivery of mesh nanoelectronics with tissue-like structure and mechanical properties into the brains of live rodents has further demonstrated nanosensors for detection of specific biomolecules 6, 27 would allow for simultaneous monitoring of biochemical and electrophysiological cellular responses in an innervated synthetic tissue. Looking to the future and the potential for implanted innervated tissue patches, it would also be interesting to explore incorporation of wireless I/O elements. It is also important to recognize that the current paradigm for mesh nanoelectronics-innervated tissue already shows unique capabilities as a platform for pharmacological screening and pathology studies in realistic 3D tissue models. In addition, mesh nanoelectronics can also serve as active tissue scaffolds for regenerative medicine enabling monitoring and control of tissue development in 3D using the individually addressable devices. 12, 21 The mesh nanoelectronics paradigm also opens a myriad of possibilities as in vivo brain probes (Figure 8 ). For example, we believe that pushing the physical limits of mesh nanoelectronics probes by incorporating nanowire FETs 2, 6, 28 to form synapselike junctions with neurites can provide unique opportunities for highly localized recording and modulation of LFPs and APs 7, 8 and even afford chronic intracellular recording via surface modification to promote cell internalization. 9, 29 Similarly, specific functionalization of the ultraflexible mesh nanoelectronics could enable specific cell type or neuron subtype targeting, especially given the absence of an immune response postimplantation. 14, 19 The current capabilities of mesh nanoelectronics to record and stimulate single-neuron level activities with long-term chronic stability also can now provide previously unavailable data crucial for understanding important questions in brain science, such as the natural and pathological aging of brain involving long-term physiological changes that must be quantified on the millisecond and micrometer scales of individual neurons. 30 Last, seamless integration of mesh nanoelectronics with the neural tissue over long time periods should make it an ideal platform for brain−machine and deep brain stimulation interfaces where stable single-unit recording would provide unique advances for neuroprosthetic control 31 and closed-loop implants for Parkinsonian patients. 
